Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianrun Liu

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
The Journal of Clinical Investigation|April 5, 2016
c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastomaMenggui Huang, Tianrun Liu, Peihong Ma, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 5, 2025
Spatial Transcriptomics Reveals Transcriptomic and Immune Microenvironment Reprogramming during Thyroid Carcinoma DedifferentiationKang Ning, Bu Zou, Yongchao Yu, et al.
International Journal of Surgery (London, England)|November 19, 2025
The dynamic changes and precise classification of parathyroid function within one year after thyroid cancer surgeryKang Ning, Yarong Liang, Taonong Cai, et al.
Frontiers in Immunology|December 29, 2025
Intratumoral delivery of PD-1/PD-L1 and CTLA-4 inhibitors for recurrent/refractory solid tumors: a proof-of-concept treatment strategyHongye Tan, Noor Ul Huda Shah, Bingjia He, et al.
Signal Transduction and Targeted Therapy|April 7, 2026
Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 studyShuang Huang, Feng Liu, Song Qu, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
The Journal of Clinical Investigation|April 5, 2016
c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastomaMenggui Huang, Tianrun Liu, Peihong Ma, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 5, 2025
Spatial Transcriptomics Reveals Transcriptomic and Immune Microenvironment Reprogramming during Thyroid Carcinoma DedifferentiationKang Ning, Bu Zou, Yongchao Yu, et al.
International Journal of Surgery (London, England)|November 19, 2025
The dynamic changes and precise classification of parathyroid function within one year after thyroid cancer surgeryKang Ning, Yarong Liang, Taonong Cai, et al.
Frontiers in Immunology|December 29, 2025
Intratumoral delivery of PD-1/PD-L1 and CTLA-4 inhibitors for recurrent/refractory solid tumors: a proof-of-concept treatment strategyHongye Tan, Noor Ul Huda Shah, Bingjia He, et al.
Signal Transduction and Targeted Therapy|April 7, 2026
Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 studyShuang Huang, Feng Liu, Song Qu, et al.
Pageof 5